IBM's Earnings Call on October 21: A Make-or-Break Moment for the Company

IBM's upcoming earnings call on October 21 is a critical moment for the company as it seeks to convince investors that its turnaround plan is more than just a slide deck. The Armonk-based technology giant has been generating headlines with its research arm, but its core business has disappointed, leading to a 22% decline in shares since the start of the year.

The key figure for IBM's investment case is currency-adjusted revenue growth, which management trimmed to a range of 4% to 5% for the full-year 2026. A strong third-quarter performance would confirm this target and help close the confidence deficit that has built up over the summer, while missing it could deepen doubts about the pace of IBM's reinvention.

The company's research pipeline has been productive in recent months, with notable developments including a collaboration with NASA on an open-source lunar foundation model and state backing from the U.S. Department of Commerce under the CHIPS and Science Act. However, a skills gap that IBM's own research arm has quantified could slow enterprise rollouts of complex software.